Astatine-211 (At-211) is a promising alpha particle emitter
for targeted radionuclide therapy. Since its daughter isotope
(polonium-211(Po-211)) emits characteristic X-rays of about 80 keV,
the distribution of At-211 in the body can be imaged by detecting
the X-rays with a scintillation camera. However, the isotopes also
emit high-energy gamma photons that are collimated with difficulty
for a parallel-hole collimator of a clinical scintillation camera
system, and thus the selection of a collimator is important. In this
study, we compared the performances of low-energy high-resolution
(LEHR), low-energy all-purpose (LEAP), medium-energy (ME), and
high-energy (HE) parallel-hole collimators for At-211 using Monte
Carlo simulation. We simulated a clinical scintillation camera
system with the collimators using the Geant4 toolkit. The energy
spectra, sensitivities, and spatial resolutions for the point source
of At-211 were evaluated. Moreover, we simulated imaging of six
sphere sources of At-211 in a 1-cm-thick cylindrical phantom filled
with At-211 solution to evaluate image contrast. All of the results
in this study are simulation data. The spatial resolution with LEHR
was 7.6 mm full width at half maximum (FWHM) and the highest
between collimators, while the sensitivity with LEAP was 85 cps/MBq
and the highest. The image contrast acquired with the ME collimator
was superior to those with the other collimators. We concluded that
the LEHR, LEAP, and ME collimators had their advantages, so an
optimum collimator should be selected depending on the purpose of
imaging of At-211, although there was no advantage in using the HE
collimator for the imaging of At-211.